yingweiwo

Others 12

Others 12

Others 12 related products

Structure Cat No. Product Name CAS No. Product Description
Shinpterocarpin V61470 Shinpterocarpin 157414-04-5 Shinpterocarpin is a flavonoid present in Glycyrrhiza glabra L.
Sialylglycopeptide V61375 Sialylglycopeptide 67299-24-5 Sialylglyco peptide is an N-glycoglycan and sialoglycopeptide.
Sialyllacto-N-tetraose b V61605 Sialyllacto-N-tetraose b 64003-54-9 Sialyllacto-N-tetraose b is a sialic acid oligosaccharide naturally present in mammalian milk.
SIC5-6 V62150 SIC5-6 2410846-16-9 SIC5-6 is a potent Separase inhibitor.
SID 7969543 V62394 SID 7969543 868224-64-0 SID 7969543 is a selective SF-1 (steroidogenic factor 1, NR5A1) inhibitor (antagonist) with IC50 of 760 nM.
SID7970631 V64573 SID7970631 868224-75-3 SID7970631, an isoquinolinone analogue, is a potent and specific submicromolar SF-1 inhibitor (IC50=260 nM).
Sifalimumab (MEDI-545; MDX 1103) V74917 Sifalimumab (MEDI-545; MDX 1103) 1006877-41-3 Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody (mAb) that can inhibit abnormal immune activity via binding to multiple interferon-α subtypes.
SIK1 activator 1 V57937 SIK1 activator 1 2769850-83-9 SIK1 activator 1 has significant inhibitory activity on hepatic gluconeogenesis by enhancing the phosphorylation of SIK1 and improving the hyperglycemic state of type 2 diabetic mice.
Simufilam (PTI-125) V62020 Simufilam (PTI-125) 1224591-33-6 Simufilam (PTI-125) may be utilized to screen candidate active molecules.
Simufilam dihydrochloride (PTI-125 dihydrochloride) V62486 Simufilam dihydrochloride (PTI-125 dihydrochloride) 2480226-06-8 Simufilam (PTI-125) diHCl may be utilized to screen candidate active molecules.
Simufilam hydrochloride (PTI-125 hydrochloride) V64231 Simufilam hydrochloride (PTI-125 hydrochloride) 2480226-07-9 Simufilam (PTI-125) HCl may be utilized to screen candidate active molecules.
Sinomenine N-oxide ((+)-Sinomenine N-oxide) V56847 Sinomenine N-oxide ((+)-Sinomenine N-oxide) 1000026-77-6 Sinomenine N-oxide has anti-angiogenic, anti-inflammatory and anti-rheumatic effects.
Sirpiglenastat (DRP-104) V64279 Sirpiglenastat (DRP-104) 2079939-05-0 Sirpiglenastat (DRP-104) is a broadly acting glutamine antagonist.
SK-3-91 V64278 SK-3-91 2769753-23-1 SK-3-91 is a multikinase degrader that collectively induces degradation of the largest number of unique kinases (over 125 unique kinases).
SLK/STK10-IN-1 V64227 SLK/STK10-IN-1 264210-49-3 SLK/STK10-IN-1 is a potent and specific SLK and STK10 inhibitor (antagonist) with nanomolar potency.
SMD-3040 intermediate-2 V59628 SMD-3040 intermediate-2 2632308-00-8 SMD-3040 intermediate-2 is an intermediate for the synthesis of SMD-3040.
Smilagenin acetate V62112 Smilagenin acetate 4947-75-5 Smilagenin acetate is a sapogenin analogue.
SN-38-CO-DMEDA TFA V58377 SN-38-CO-DMEDA TFA 1224601-17-5 SN-38-CO-DMEDA TFA is an intermediate product for the synthesis of antibody drug conjugate LND1035.
Snailase V57439 Snailase 158736-45-9 Snailase is an enzyme mixture consisting of more than 20 enzymes, which is often used for enzymatic hydrolysis of purified flavonoid glycosides.
SNX7 V58854 SNX7 685097-43-2 SNX7 is a cyclin-dependent kinase inhibitor (CDKI) pathway inhibitor.
Contact Us